Trials / Sponsors / Biofabri, S.L
Biofabri, S.L
Industry · 5 registered clinical trials — 1 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | Efficacy, Safety and Immunogenicity Evaluation of MTBVAC in Newborns in Sub-Saharan Africa Tuberculosis | Phase 3 | 2022-10-17 |
| Unknown | Treatment of High-risk Non-muscle Invasive Bladder Cancer With IMUNO BGC Moreau RJ as Prophylaxis Bladder Cancer | Phase 2 | 2019-05-17 |
| Completed | Dose-Defining Safety and Immunogenicity Study of MTBVAC in South African Neonates Tuberculosis | Phase 2 | 2019-02-12 |
| Completed | Dose-escalation Safety and Immunogenicity Study to Compare MTBVAC to BCG in Newborns With a Safety Arm in Adul Tuberculosis | Phase 1 / Phase 2 | 2015-09-01 |
| Completed | Dose-Escalation Study to Evaluate the Safety and Immunogenicity of MTBVAC Vaccine in Comparison With BCG Vacci Tuberculosis, Healthy | Phase 1 | 2013-01-01 |